Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...

Can DexCom still be a millionaire maker? Additionally, DexCom isn't a small company anymore. The stock's market cap is almost $27 billion even after falling 50%.

DexCom is all geared up to announce its second-quarter earnings towards the end of this month, and analysts anticipate a single-digit bottom-line growth.

DexCom DXCM -0.78% and Abbott Diabetes Care entered a settlement and patent cross-license agreement, resolving all outstanding litigation between the companies. The companies have been involved in ...

Shares of DexCom Inc. tumbled more than 40% on Friday and were headed for their worst percentage drop on record, a day after the maker of diabetes-management equipment shocked investors with a cut ...

DexCom generates nearly $4 billion in annual sales on a user base of just 2.5 million to 2.6 million patients worldwide, a tiny fraction of those with diabetes.

Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.

SAN DIEGO-- (BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the ...

Medical device maker Dexcom beat fourth-quarter sales estimates helped by resilient demand for its continuous glucose monitors (CGMs) used by patients with diabetes.

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients and ...